Brooks O'Neil
Stock Analyst at Lake Street
(0.66)
# 4,117
Out of 5,150 analysts
34
Total ratings
29.41%
Success rate
-21.07%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $4.82 | +107.47% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.12 | +156.41% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $23.41 | -48.74% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.97 | +60.97% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.40 | +733.33% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $106.41 | +3.37% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $11.38 | +163.62% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $4.91 | +429.53% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $39.22 | +40.23% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $13.00 | +38.46% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.90 | +124.72% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.87 | +74.22% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.29 | +7.04% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.19 | +5,692.52% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $24.66 | +417.03% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $4.82
Upside: +107.47%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.12
Upside: +156.41%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $23.41
Upside: -48.74%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.97
Upside: +60.97%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.40
Upside: +733.33%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $106.41
Upside: +3.37%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $11.38
Upside: +163.62%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $4.91
Upside: +429.53%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $39.22
Upside: +40.23%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $13.00
Upside: +38.46%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.90
Upside: +124.72%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.87
Upside: +74.22%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.29
Upside: +7.04%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.19
Upside: +5,692.52%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $24.66
Upside: +417.03%